Cargando…

Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices

AIMS: Atrial high rate episodes (AHREs) are associated with increased risks of thromboembolism and cardiovascular mortality. However, the clinical characteristics of patients developing AHRE of various durations are not well studied. METHODS AND RESULTS: This was an ancillary analysis of the multice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazawa, Kazuo, Pastori, Daniele, Martin, David T, Choucair, Wassim K, Halperin, Jonathan L, Lip, Gregory Y H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892042/ https://www.ncbi.nlm.nih.gov/pubmed/34426836 http://dx.doi.org/10.1093/europace/euab186

Ejemplares similares

Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices
por: Pastori, Daniele, et al.
Publicado: (2018)

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes
por: Miyazawa, Kazuo, et al.
Publicado: (2019)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C(2)HEST Score: The West Birmingham Atrial Fibrillation Project
por: Li, Yan‐Guang, et al.
Publicado: (2021)

Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation
por: Imberti, Jacopo Francesco, et al.
Publicado: (2022)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

PO-02-028 NEGATIVE EFFECTS OF COVID-19 ON THE IMPLANTATION RATE OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR DEVICE.
por: Udongwo, Ndausung, et al.
Publicado: (2023)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
por: Khan, Ahsan A., et al.
Publicado: (2019)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Rate‐responsive pacing and atrial high rate episodes in cardiac resynchronization therapy patients: Is low heart rate the key?
por: Biffi, Mauro, et al.
Publicado: (2019)

Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
por: Braunschweig, Frieder, et al.
Publicado: (2019)

Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017)

Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions
por: Zecchin, Massimo, et al.
Publicado: (2020)

A new approach for implantation of a cardiac resynchronization therapy–defibrillator in a patient with bilateral pectoral neurostimulation devices
por: Tsukuda, Saori, et al.
Publicado: (2018)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
por: Akerström, Finn, et al.
Publicado: (2020)

Implantation of left atrial-ventricular epicardial pacemaker system and subcutaneous implantable cardioverter-defibrillator in a single setting: The “extravascular” cardiac resynchronization therapy
por: Sharma, Saumya, et al.
Publicado: (2019)

Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole
por: Hindricks, Gerhard, et al.
Publicado: (2023)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2020)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD)
por: Hasin, Tal, et al.
Publicado: (2021)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort
por: Varma, Niraj, et al.
Publicado: (2017)

Implantation of a Resynchronization Implantable Cardioverter Defibrillator in a Patient with Persistent Left Superior Vena Cava
por: Antonelli, Dante, et al.
Publicado: (2007)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Implantation of a cardiac resynchronization therapy and defibrillation system using a robotic approach
por: Amraoui, Sana, et al.
Publicado: (2015)

What do we do about atrial high rate episodes?
por: Boriani, Giuseppe, et al.
Publicado: (2020)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer
por: Landolina, Maurizio, et al.
Publicado: (2015)

HATCH Score and Left Atrial Size Predict Atrial High-Rate Episodes in Patients With Cardiac Implantable Electronic Devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
por: Theuns, Dominic A.M.J., et al.
Publicado: (2011)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy
por: Sticherling, Christian, et al.
Publicado: (2018)

The performance of five models compared with atrial high rate episodes predicts new atrial fibrillation after cardiac implantable electronic devices implantation
por: Chen, Ju‐Yi, et al.
Publicado: (2022)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Prevalence and Predictors of Clinically Relevant Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices
por: Kim, Min, et al.
Publicado: (2020)

The utilization of atrial sensing dipole in single lead implantable cardioverter defibrillator for detection of new‐onset atrial high‐rate episodes or subclinical atrial fibrillation: A systematic review and meta‐analysis
por: Pung, Xuanming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98lltc1a5c8e8ro848etjf0k94